Cadrenal Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cadrenal Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CVKD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001937993
Board of directors
-
Glynn Wilson · DirectorSince 2023
-
John Raymond Murphy · DirectorSince 2023
-
Lee Scott Golden · DirectorSince 2025
-
Quang X. Pham · Director · Chairman and CEOSince 2023
-
Robert Lisicki · DirectorSince 2023
-
Steven Zelenkofske · DirectorSince 2023
Chief executives
Quang X. Pham
· CEO and Chairman
Since January 2023
Board connections
3 of this board's directors also sit on 4 other boards.
- via Glynn Wilson
- via Glynn Wilson
- via John Raymond Murphy
- via Robert Lisicki
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $693,799
- 37 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Quang X. Pham Director, Officer (Chairman and CEO), 10% owner | Open-market sale | −7,400 | $3.03 | $22,422 |
| Jun 26, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −9,029 | $3.05 | $27,538 |
| Jun 25, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −2,127 | $3.00 | $6,381 |
| Jun 23, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −2,277 | $3.20 | $7,286 |
| Jun 22, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −9,167 | $3.55 | $32,543 |
| Jun 17, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −513 | $3.16 | $1,621 |
| Jun 16, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,613 | $3.18 | $11,489 |
| Jun 15, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,666 | $3.58 | $13,124 |
| Jun 12, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −12,996 | $3.94 | $51,204 |
| Jun 11, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −1,462 | $4.12 | $6,023 |
| Jun 10, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,500 | $4.21 | $14,735 |
| Jun 9, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −12,992 | $4.06 | $52,748 |
| Jun 8, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −5,893 | $4.38 | $25,811 |
| Jun 5, 2026 | Quang X. Pham Director, Officer (CEO and Chairman), 10% owner | Open-market sale | −2,064 | $4.42 | $9,123 |
| Jun 4, 2026 | Quang X. Pham Director, Officer (CEO and Chairman), 10% owner | Open-market sale | −3,898 | $4.41 | $17,190 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.